Keypoints：U.S. stocks, U.S. bonds, and gold: The Jackson Hole annual meeting revealed the divergence of global central banks and the uneven pace of the global economic cycle. U.S. bond yields soared to new highs in 2008 and parted ways with gold prices. A Paradigm shift is quietly kicking off, but the recent wave of selling in US stocks has weakened. The attractiveness of U.S. debt may decline, and gold will shine brightly. $S&P 500(.SPX)$ $NASDAQ(.IXIC)$ $Gold - main 2312(GCmain)$ $iShares 20+ Year Treasury Bond ETF(TLT)$ ASIA STOCKS: Chinese markets have long understood stamp duty cuts and their implications. T
Investing in the stock market is a delicate dance between risk and reward. The allure of catching a plummeting stock, often referred to as "catching falling knives," can be both enticing and perilous. One company that has recently attracted my attention for employing this strategy is $Pfizer(PFE)$, a pharmaceutical giant with a history of market fluctuations. But is this strategy a prudent move, or is it a risky gamble that could result in painful losses? Let's dissect the situation and explore the pros and cons of catching the falling knives of Pfizer. The temptation of catching the falling knives of Pfizer Understanding the Metaphor The metaphor of "catching falling knives" paints a vivid image of trying to grasp a sharp object in freefall, a ris